Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy

Completed

• Conditions: Rheumatoid Arthritis
• Interventions: Drug: DMARD

• Registration Number: NCT00116714
• Lead Sponsor: Amgen

Brief Summary

The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently used in the management of rheumatoid arthritis (RA). It is anticipated that study data may help improve the quality of information upon which clinical decisions are based.

Detailed Description

Not available

Study Timeline

• Study Start: 2001-10
• Study First Submitted: 2005-06-30
• Study First Submitted QC: 2005-06-30
• Study First Posted: 2005-07-01
• Primary Completion: 2007-12
• Study Completion: 2008-10
• Status Verified: 2011-05
• Last Update Submitted: 2011-05-05
• Last Update Posted: 2011-05-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 4968

Inclusion Criteria

• Fulfillment of the 1987 American Rheumatism Association criteria for RA
• Currently requiring a new DMARD (change or addition)

Exclusion Criteria

• Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol
• Nursing or pregnant women
• Patients with active infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Observation	DMARD	-